Recent studies reveal breakthroughs in disease management: a novel plasma synuclein test enhances Parkinson’s diagnosis with improved sensitivity; a precise treatment timing strategy may boost cancer immunotherapy outcomes based on UC San Diego research; and a mitophagy mechanism clarification could unlock therapies for Parkinson’s disease. These advances reflect the ongoing integration of molecular insights into clinical approaches.